MEDICAL INFORMATION FOR HEALTH CARE PROFESSIONALS |
|
|
|
|
|
|
Reimbursement status of HIV medications in Ontario download .pdf version here |
|
|
Ont. Drug Distr. |
Ontario Drug Benefit/Trillium: |
Other |
|
|
Monitoring Program |
Formulary |
Facilitated Access (F/A) |
Limited Use |
Section 8 |
|
|
Antiretro-virals |
AZT 100 mg capsules, ddI, ddC |
|
Abacavir, AZT 300 mg tablets, 3TC, AZT/3TC (Combivir), d4T,Saquinavir (Invirase and Fortovase), Ritonavir, Indinavir, Nelfinavir, Delavirdine,
Efavirenz, Nevirapine (limited use) |
Amprenavi r, Lopinavir/ ritonavir |
d4T oral liquid (SAP) |
|
Antivirals |
|
|
Ganciclovir IV, Acyclovir |
Famciclovir, Valacyclovir |
Oral Ganciclovi r |
Foscarnet, Cidofovir, Valganciclo vir (SAP) |
|
Antifun-gals |
|
Clotrimazol e vag tabs, Nystatin, Ketoconaz ole, IV Ampho B |
Fluconazole, Itraconazole capsules and solution |
|
Flucytosin e, liposomal amphoteric in (Ambisom e) |
Ampho B lozenges, Ampho B oral solution, Clotrimazole troches, (SAP) |
|
PCP/Toxo Agents |
Aerosolized Pentamidine |
TMP/SMX, Trimethopri m. Clindamyci n, Folinic Acid |
Atovaquone liquid, Pyrimethamine |
|
Primaquine |
Dapsone, Sulfadiazine , Trimetrexat e (SAP) |
|
Mycobact erials |
|
Isoniazid, Rifampin, Pyrazinami de, Ethambutol, B6, Clarithromy cin 250 mg tabs, Azithromyc in 250 mg caps, Ciprofloxac in |
Azithromycin 600 mg tablets |
Rifabutin, Clarithromycin liquid, Azithromycin liquid |
Amikacin |
Clofazimine, streptomyci n (SAP); INH, RIF, ETM, PZA, B6 (CDCNU); 2nd line TB drugs (Toronto Public Health) |
|
Misc. |
|
Megace, Nabilone, most NSAIDs, codeine, morphine, hydromorp hone, oxycodone , |
Doxycycline, Paramomycin, Nutritional products, Pneumococcal vaccine |
Dronabinol, Fentanyl patch, gabapentin, Ondansetron, pancreatic enzyme (Cotazyme ECS 20), Interferon -2a, interferon -2b |
Ketorolac, G-CSF (Neupogen ), octreotide, somatropin (Serostim), imiquimod (Aldara) |
Albendazol e, GM-CSF, Thalidomide (SAP); oxandrolon e (SAP - but need to pay in advance: call (613) 957-1063) |
|
Prepared by: Alice Tseng, Pharm.D., Toronto General Hospital Updated May 9, 2001 |
|
|
|
Obtaining antiretrovirals in Ontario |
|
Drug |
Status |
Patient Criteria |
MD Criteria |
Paperwork/Phar macy |
Cost/Month |
|
Nucleoside Reverse Transcriptase Inhibitors: |
|
abacavir(Ziagen) |
ODB Limited Use |
ODB/Trillium plan |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacy. |
$375.00 |
|
AZT, zidovudine 100 mg capsules(Retrovir) |
Ont. Drug Distribution/ Monitoring Program |
Ontario Health CardCD4<500 |
|
Antiretroviral Registration Form to Ont. Drug Distribution/Monitori ng Programfollow-up info q3months Pick up Rx at designated hospital
pharmacy |
$306.00 |
|
AZT 300 mg/3TC 150 mg tablets (Combivir) |
ODB Limited Use |
ODB/Trillium plan |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacy |
$570.00 |
|
ddI tablets, didanosine(Videx) |
Ont. Drug Distribution/ Monitoring Program |
Ontario Health CardCD4<200 |
|
Antiretroviral Registration Form to Ont. Drug Distribution/Monitori ng Programfollow-up info q3months Pick up Rx at designated hospital
pharmacy |
$115.50 - $184.80 |
|
ddI pediatric oral solution (Videx) |
Ont. Drug Distribution/ Monitoring Program/ section 8 |
Ontario Health CardCD4<200 |
|
Antiretroviral Registration Form to Ont. Drug Distribution/Monitori ng Program; follow-up info q3monthsPick up Rx at designated hospital pharmacy
Section 8 application (incl. cost of Maalox & extemporaneous compounding) made to Director of Drug Programs Branch, fax (416) 327-8123 |
ddI + cost of Maalox + 10.49 disp. fee |
|
ddC, zalcitabine(Hivid) |
Ont. Drug Distribution/ Monitoring Program |
Ontario Health CardCD4<300 |
|
Antiretroviral Registration Form to Ont. Drug Distribution/Monitori ng Program follow-up info q3monthsPick up Rx at designated hospital pharmacy
|
$154.50 - $193.50 |
|
3TC, lamivudine |
ODB Limited Use |
ODB/Trillium planused with another -RV |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacyNB: LU code 313 for PEP (for 2 months) |
$264.00 |
|
d4T, stavudine(Zerit) |
ODB Limited Use |
ODB/Trillium planused with another -RV (not for monotherapy) |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacy |
$226.80-$255.00 |
|
Protease Inhibitors: |
|
amprenavir (Ageneras e) |
Section 8 |
ODB/Trillium plan |
|
Section 8 application made to Director of Drug Programs Branch, fax (416) 327-8123. |
$1013.76 |
|
indinavir (Crixivan) |
ODB Limited Use |
ODB/Trillium planused with another -RV (but not with ritonavir or saquinavir) |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 152) to patient with Rx to take to pharmacyNB: LU code 313 for post-exposure
prophylaxis (2 months) |
$484.79 |
|
lopinavir/ ritonavir (Kaletra) |
Section 8 |
ODB/Trillium plan |
|
Section 8 application made to Director of Drug Programs Branch, fax (416) 327-8123. |
$651.24 |
|
nelfinavir (Viracept) |
ODB Limited Use |
ODB/Trillium planused with another -RV |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacyNB: LU code 313 for PEP (2 months) |
$491.40-546.00 |
|
ritonavir liquid or capsules (Norvir) |
ODB Limited Use |
ODB/Trillium planused with another -RV (but not with indinavir) |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 246) to patient with Rx to take to pharmacy |
$480.74 |
|
saquinavir- hgc (Invirase) or saquinavir- sgc (Fortovase ) |
ODB Limited Use |
ODB/Trillium planused with another -RV (but not indinavir) |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 247) to patient with Rx to take to pharmacy |
$491.40-550.80 |
|
Non-Nucleoside Reverse Transcriptase Inhibitors: |
|
delavirdine(Rescriptor ) |
ODB Limited Use |
ODB/Trillium planused with another -RV |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacy |
$258.41 |
|
nevirapine(Viramune) |
ODB Limited Use |
ODB/Trillium planused with another -RV |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacy |
$279.00 |
|
efavirenz (Sustiva) |
ODB Limited Use |
ODB/Trillium planused with another -RV |
MD on ODB Facilitated Access List |
Limited Use prescription form (reason for use code 153) to patient with Rx to take to pharmacy |
$398.70 |
|
Alice Tseng, Pharm.D., Toronto General Hospital, Toronto, ON Updated May 16, 2001 download .pdf version here |
|
|